Research Papers
All research highlights
Public health
Published by
Nishan Katuwal
HEV is estimated to cause approximately 20 million new infections annually, leading to around 3.3 million symptomatic cases and 70,000 deaths. However, these figures may be underestimated due to limit...
HEV is estimated to cause approximately 20 million new infections annually, leading to around 3.3 million symptomatic cases and 70,000 deaths. However, these figures may be underestimated due to limit...
Pathology
Virus-host interaction
Published by
-
Hepatitis E virus (HEV) is a widespread zoonotic pathogen and the leading cause of acute viral hepatitis globally. Recent studies have revealed that HEV infection is associated with a broad spectrum o...
Hepatitis E virus (HEV) is a widespread zoonotic pathogen and the leading cause of acute viral hepatitis globally. Recent studies have revealed that HEV infection is associated with a broad spectrum o...
Hepatology
Public health
Vaccine
Virology
Published by
Susanne Dudman, Asma Aziz
We conducted a large phase 4, double-blind, cluster-randomised trial in 67 villages in Matlab, Bangladesh, and hereby share some of our results. Between 2017 and2021, 19 460 participants were randomis...
We conducted a large phase 4, double-blind, cluster-randomised trial in 67 villages in Matlab, Bangladesh, and hereby share some of our results. Between 2017 and2021, 19 460 participants were randomis...
Clinical Trial
Prevention
Public health
Vaccine
Published by
Asma Aziz
The safety of the HEV vaccine (Hecolin®) during or shortly before pregnancy remains uncertain, with only two studies from China providing limited insights. These studies had significant limitations s...
The safety of the HEV vaccine (Hecolin®) during or shortly before pregnancy remains uncertain, with only two studies from China providing limited insights. These studies had significant limitations s...
Animal reservoir
One health
Published by
Kush Kumar Yadav, Scott Kenney
Rat HEV (Rocahepevirus ratti) is an emerging infectious disease with a global concern. Initial experiments in 2013 with rat HEV concluded it to be noninfectious to humans as evidenced by the absence o...
Rat HEV (Rocahepevirus ratti) is an emerging infectious disease with a global concern. Initial experiments in 2013 with rat HEV concluded it to be noninfectious to humans as evidenced by the absence o...
Vaccine
Published by
Martin Eiden
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis globally. Currently, no causal treatment or universally licensed vaccine exists. Several recombinant HEV vaccines have been develope...
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis globally. Currently, no causal treatment or universally licensed vaccine exists. Several recombinant HEV vaccines have been develope...
Public health
Published by
Maria Belen Pisano
The hepatitis E virus (HEV, specie Paslahepevirus balayani) is responsible for a liver disease that affects ∼ 20 million people worldwide every year, especially in low- and middle-income countries w...
The hepatitis E virus (HEV, specie Paslahepevirus balayani) is responsible for a liver disease that affects ∼ 20 million people worldwide every year, especially in low- and middle-income countries w...
Experimental model
Immunity
Published by
Qiyu He, Lin Wang
Chronic hepatitis E mostly occurs in organ transplant recipients and can lead to rapid liver fibrosis and cirrhosis. Previous studies found that the development of chronic hepatitis E virus (HEV) infe...
Chronic hepatitis E mostly occurs in organ transplant recipients and can lead to rapid liver fibrosis and cirrhosis. Previous studies found that the development of chronic hepatitis E virus (HEV) infe...
Virus-host interaction
Published by
Yijin Wang
Hepatitis E virus (HEV) infection in pregnant women is associated with a wide spectrum of adverse consequences for both mother and fetus. The high mortality in this population appears to be associated...
Hepatitis E virus (HEV) infection in pregnant women is associated with a wide spectrum of adverse consequences for both mother and fetus. The high mortality in this population appears to be associated...
Virus-host interaction
Published by
Kush Kumar Yadav, Scott Kenney
Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis globally. In the last few decades, HEV has been described as causing extrahepatic clinical manifestations including neurological, ...
Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis globally. In the last few decades, HEV has been described as causing extrahepatic clinical manifestations including neurological, ...
0 - 8 of 87 items
EVENTS
2025-01-18
International Joint Meeting on Viral Infections of the Liver and the Heart (2025)
Day two of this symposium will place a special emphasis on Hepatitis E — a virus that, despite being the most common cause of viral hepatitis, offers a valuable opportunity for further research and understanding. Venue: Cantinerie Berlin Gustav-Meyer-Allee 25 13355 Berlin, Germany. Organisers: Prof. Dr. Jens Kurreck, Dr. rer. nat. Daniel Todt, Prof. Dr. med. Heiner Wedemeyer, More information: Medizinische Hochschule Hannover : International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart (mhh.de)
Day two of this symposium will place a special emphasis on Hepatitis E — a virus that, despite being the most common cause of viral hepatitis, offers a valuable opportunity for further research and understanding. Venue: Cantinerie Berlin Gustav-Meyer-Allee 25 13355 Berlin, Germany. Organisers: Prof. Dr. Jens Kurreck, Dr. rer. nat. Daniel Todt, Prof. Dr. med. Heiner Wedemeyer, More information: Medizinische Hochschule Hannover : International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart (mhh.de)
